Bladder Cancer, Urothelial Carcinoma News Articles

Bladder Cancer News

BLADDER CANCER ADVISOR

Bladder Cancer News

doctors performing surgery

EAU Issues Updated UTUC Guidelines

The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.

Pembrolizumab Benefits Durable in BCG-Unresponsive High-Risk NMIBC

After a median time of 28.4 months, 40.6% of patients treated with pembrolizumab for high-risk nonmuscle-invasive bladder unresponsive to bacillus Calmette-Guérin (BCG) therapy had a complete response to the drug, and the median duration of response was 16.2 months.
Though early-stage bladder cancer is infrequently fatal, the decrease in recurrence rates has a mean

5-ARIs Do Not Lower Bladder Cancer Risk

Previous retrospective studies have suggested that 5-alpha-reductase inhibitors may beneficial effects on bladder cancer development and/or recurrence, but a prospective cohort study found no protective effect.